Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-06-12T07:35:20.247Z Has data issue: false hasContentIssue false
  • English
  • Français

The effects of oral vitamin supplementation on cardiovascular risk factors

Published online by Cambridge University Press:  18 April 2008

J. V. Woodside ,
I. S. Young ,
J. W. G. Yarnell ,
D. McMaster  and
A. E. Evans
J. V. Woodside
Affiliation:
Department of Epidemiology and Public Health, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR Department of Clinical Biochemistry, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR
I. S. Young
Affiliation:
Department of Clinical Biochemistry, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR
J. W. G. Yarnell
Affiliation:
Department of Epidemiology and Public Health, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR
D. McMaster
Affiliation:
Department of Medicine, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR
A. E. Evans
Affiliation:
Department of Epidemiology and Public Health, Institute of Clinical Science, The Queen's University of Belfast, Belfast BT12 7AR
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Postgraduate Symposium
Information
Proceedings of the Nutrition Society , Volume 56 , Issue 1B , March 1997 , pp. 479 - 488
Copyright
Copyright © The Nutrition Society 1997

References

REFERENCES

Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkaniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T. & Ehnholm, E. (1994). Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106, p. 9–19.CrossRefGoogle Scholar
Arnesen, E., Refsum, H., Bonaa, K. H., Ueland, P. M., Forde, O. H. & Nordrehaug, J. E. (1995). Serum total homocysteine and coronary heart disease. International Journal of Epidemiology 24, p. 704–709.CrossRefGoogle ScholarPubMed
Blom, H. J., Kleinveld, H. A., Boers, G. H. J., Demacker, P. N. M., Haklemmers, H. L. M., Poelepothoff, M. T. W. B. T. & Trijbels, J. M. F. (1995). Lipid peroxidation and susceptibility of low-density-lipoprotein to in-vitro oxidation in hyperhomocysteinemia. European Journal of Clinical Investigation 25, p. 149–154.CrossRefGoogle Scholar
Boushey, C. J., Beresford, S. A. A., Omenn, G. S. & Motulsky, A. G. (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association 274, p. 1049–1057.CrossRefGoogle ScholarPubMed
Brattstrom, L., Israelsson, B., Lindgarde, F. & Hultberg, B. (1988). Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism 37, p. 175–178.CrossRefGoogle ScholarPubMed
Carew, T. E., Schwenke, D. C. & Steinberg, D. (1987). Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proceedings of the National Academy of Sciences USA 84, p. 7725–7729.CrossRefGoogle ScholarPubMed
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B. & Graham, I. (1991). Hyperhomocysteinemia: An independent risk factor for vascular disease. New England Journal of Medicine 324, p. 1149–1155.CrossRefGoogle ScholarPubMed
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J. & Fogelman, A. M. (1990). Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial and smooth muscle cells. Proceedings of the National Academy of Sciences USA 87, p. 5134–5138.CrossRefGoogle Scholar
Cuskelly, G. J., McNulty, H. & Scott, J. M. (1996). Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 347, p. 657–659.CrossRefGoogle ScholarPubMed
Daugherty, A. & Rateri, D. L. (1993). Pathogenesis of atherosclerotic lesions. Cardiology Reviews 1, p. 157–166.CrossRefGoogle Scholar
Delorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J. L. & Monjaud, I. (1994). Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, p. 1454–1459.CrossRefGoogle Scholar
Editorial (1984). Progress in coronary artery disease risk-factor research: what remains to be done?. Clinical Chemistry 30, p. 1125–1127.CrossRefGoogle Scholar
Finkelstein, J. D. (1990). Methionine metabolism in mammals. Journal of Nutritional Biochemistry 1, p. 228–237.CrossRefGoogle ScholarPubMed
Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P. & Cathcart, M. K. (1995). Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. Journal of Clinical Investigation 96, p. 504–510.CrossRefGoogle Scholar
Genest, J. J. Jr, McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. F. & Malinow, M. R. (1990). Plasma homocyst(e)ine levels in men with premature coronary artery disease. Journal of the American College of Cardiology 16, p. 1114–1119.CrossRefGoogle ScholarPubMed
Gey, K. G., Puska, P., Jordan, P. & Moser, U. K. (1991). Inverse correlation between vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. American Journal of Clinical Nutrition 53 Suppl., 326–334.CrossRefGoogle ScholarPubMed
Giannini, M. J., Coleman, M. & Innerfield, I. (1975). Antithrombin activity in homocystinuria. Lancet i, p. 1094.CrossRefGoogle Scholar
Harker, L. A., Slichter, S. J., Scott, C. R. & Ross, R. (1974). Homocysteinemia: Vascular injury and arterial thrombosis. New England Journal of Medicine 291, p. 537–543.CrossRefGoogle Scholar
Harmon, D. L., Woodside, J. V., Yarnell, J. W. G., McMaster, D., Young, I. S., McCrum, E. E., Gey, K. F., Whitehead, A. S. & Evans, A. (1996). The common ‘thermolabile’ variant of methylene-tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Quarterly Journal of Medicine 89, p. 571–577.CrossRefGoogle Scholar
Harpel, P. C., Chang, V. T. & Borth, W. (1992). Homocysteine and other sulfhydry1 compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydry1 compound metabolism. Proceedings of the National Academy of Sciences USA 89, p. 10193–10197.CrossRefGoogle ScholarPubMed
Heinecke, J. W., Rosen, H., Suzuki, L. A. & Chait, A. (1987). The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. Journal of Biological Chemistry 262, p. 10098–10103.CrossRefGoogle ScholarPubMed
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willett, W. & Peto, R. (1996). Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine 334, p. 1145–1149.CrossRefGoogle ScholarPubMed
Itabe, H., Yamamoto, H., Imanaka, T., Shimamura, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y. & Takano, T. (1996). Sensitive detection of oxidatively modified low-density lipoprotein using a monoclonal antibody. Journal of Lipid Research 37, p. 45–53.CrossRefGoogle ScholarPubMed
Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C., Eckfeldt, J. H., Rosenberg, I. H., Selhub, J. & Rozen, R. (1996). Relation between folate status, a common mutation in methylentetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, p. 7–9.CrossRefGoogle Scholar
Jha, P., Flather, M., Lonn, E., Farkouh, M. & Yusuf, S. (1995). The antioxidant vitamins and cardiovascular disease. Annals of Internal Medicine 123, p. 860–872.CrossRefGoogle ScholarPubMed
Johansson, J., Olsson, A. G., Bergstrand, L., Elinder, L. S., Nilsson, S., Erikson, U., Molgaard, J., Holme, I. & Walldius, G. (1995). Lowering of HDL(2B) by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia - a probucol quantitative regression Swedish trial (PQRST) report. Arteriosclerosis, Thrombosis and Vascular Biology 15, p. 1049–1056.CrossRefGoogle Scholar
Kagan, V. E., Serbinova, E. A., Forte, T., Scita, G. & Packer, L. (1992). Recycling of vitamin E in human low density lipoproteins. Journal of Lipid Research 33, p. 385–397.CrossRefGoogle ScholarPubMed
Kang, S. S., Wong, P. W. K., Bock, H. G. O., Horwitz, A. & Grix, A. (1991a). Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. American Journal of Human Genetics 48, p. 546–551.Google ScholarPubMed
Kang, S. S., Wong, P. W. K. & Malinow, M. R. (1992). Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annual Review of Nutrition 12, p. 279–298.CrossRefGoogle ScholarPubMed
Kang, S. S., Wong, P. W. K. & Norusis, M. (1987). Homocysteinemia due to folate deficiency. Metabolism 36, p. 458–462.CrossRefGoogle ScholarPubMed
Kang, S. S., Wong, P. W. K., Susmano, A., Sora, J., Norusis, M. & Ruggie, N. (1991b). Thermolabile methylene-tetrahydrofolate reductase: An inherited risk factor for coronary artery disease. American Journal of Human Genetics 48, p. 536–545.Google ScholarPubMed
Kang, S. S., Wong, P. W. K., Zhou, J., Sora, J., Lessick, M., Ruggie, N. & Grcevich, G. (1988a). Thermolabile methylenetetra-hydrofolate reductase in patients with coronary artery disease. Metabolism 37, p. 611–613.CrossRefGoogle Scholar
Kang, S. S., Zhou, J., Wong, P. W. K., Kowalisyn, J. & Strokosch, G. (1988b). Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. American Journal of Human Genetics 43, p. 414–421.Google ScholarPubMed
Kottke-Marchant, K., Green, R., Jacobsen, D. & Dicorleto, P. (1990). Sub-cytotoxic homocysteine increases monocyte adhesion to human aortic endothelial cells. Blood 76, 511a.Google Scholar
Libby, P. & Hansson, G. K. (1991). Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Laboratory Investigation 64, p. 5–15.Google ScholarPubMed
Lindenbaum, J., Healton, E. B., Savage, D. G., Brust, J. C. M., Garrett, T. J., Podell, E. R., Marcell, P. D., Stabler, S. P. & Allen, R. H. (1988). Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New England Journal of Medicine 318, p. 1720–1728.CrossRefGoogle ScholarPubMed
McCully, K. S. (1983). Homocysteine theory of arteriosclerosis—development and current status. Atherosclerosis Reviews 11, p. 157–246.Google Scholar
Malinow, M. K. (1990). Hyperhomocyst(e)ine: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation 81, p. 2004–2006.CrossRefGoogle Scholar
Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E. & Bond, G. (1993). Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation 87, p. 1107–1113.CrossRefGoogle ScholarPubMed
Miller, J. W., Ribaya-Mercado, J. D., Russell, R. M., Shepard, D. C., Morrow, F. D., Cochary, E. F., Sadowski, J. A., Gershoff, S. N. & Selhub, J. (1992). Effect of vitamin B6 deficiency on fasting plasma homocysteine concentrations. American Journal of Clinical Nutrition 55, p. 1154–1160.CrossRefGoogle ScholarPubMed
Mudd, S. H., Levy, H. L. & Skovby, F. (1989). Disorders of transulfuration. The Metabolic Basis of Inherited Disease pp. 693–734 [Scriver, C. S., Beaudet, A. L., Sly, W. L., Valle, D.] New York: McGraw-Hill International Book Co.Google Scholar
Munnich, A., Saudubray, J.-M., Dautzenberg, M.-D., Parvy, P., Ogier, H., Girot, R., Manigne, P. & Frezai, J. (1983). Diet-responsive proconvertin (Factor VII) deficiency in homocystinuria. Journal of Pediatrics 102, p. 730–734.CrossRefGoogle ScholarPubMed
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S. & Hammar, S. (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 334, p. 1150–1155.CrossRefGoogle ScholarPubMed
Park, K. Y. & Linkswiler, H. (1970). Effect of vitamin B6 depletion in adult man on the excretion of cystathionine and other methionine metabolites. Journal of Nutrition 100, p. 110–116.CrossRefGoogle Scholar
Parthasarathy, S. (1987). Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochimica Biophysica Acta 917, p. 337–340.CrossRefGoogle ScholarPubMed
Parthasarathy, S., Khoo, J. C., Miller, E., Barnett, J., Witztum, J. L. & Steinberg, D. (1990). Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis. Proceedings of the National Academy of Sciences USA 87, p. 3894–3898.CrossRefGoogle Scholar
Perry, I. J., Refsum, H., Morris, R. W., Ebrahim, S. B., Ueland, P. M. & Shaper, A. G. (1995). Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, p. 1395–1398.CrossRefGoogle ScholarPubMed
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M. & Lusis, A. J. (1990). Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, p. 254–257.CrossRefGoogle ScholarPubMed
Rees, M. M. & Rodgers, G. M. (1993). Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thrombosis Research 71, p. 337–359.CrossRefGoogle ScholarPubMed
Riemersma, R. A., Wood, D. A., Macintyre, C. C. A., Elton, R. A., Gey, K. F. & Oliver, M. F. (1991). Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337, p. 1–5.CrossRefGoogle Scholar
Rodgers, G. M. & Conn, M. T. (1990). Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75, p. 895–901.CrossRefGoogle ScholarPubMed
Rodgers, G. M., Fryer, R. H., Wilson, B. D., Gubler, D. B. & Fitzgerald, L. A. (1993). Homocysteine, a risk factor for vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Clinical Research 41, 19A.Google Scholar
Rodgers, G. M. & Kane, W. H. (1986). Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. Journal of Clinical Investigation 77, p. 1909–1916.CrossRefGoogle ScholarPubMed
Rosenfeld, M. E. (1991). Oxidized LDL affects multiple atherogenic cellular responses. Circulation 83, p. 2137–2140.CrossRefGoogle ScholarPubMed
Salonen, J. T., Yla-Herttuala, S., Yamamoto, R., Butler, R., Korpela, H., Salonen, R., Nyyssonen, K., Palinski, W. & Witztum, J. L. (1992). Autoantibody against oxidized LDL ana progression of carotid atheroscierosis. Lancet 339, p. 883–887.CrossRefGoogle Scholar
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J. & Rosenberg, I. H. (1995). Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New England Journal of Medicine 332, p. 286–291.CrossRefGoogle ScholarPubMed
Selhub, J., Jacques, P. F., Wilson, P. W. F., Rush, D. & Rosenberg, I. H. (1993). Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Journal of the American Medical Association 270, p. 2693–2698.CrossRefGoogle Scholar
Slavik, M., Smith, K. J. & Blanc, O. (1982). Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of pyridozine. Biochemical Pharmacology 31, p. 4089–4092.CrossRefGoogle Scholar
Smith, C., Mitchinson, M., Aruoma, O. I. & Halliwell, B. (1992). Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 286, p. 901–905.CrossRefGoogle ScholarPubMed
Smolin, L. A. & Benevenga, N. J. (1982). Accumulation of homocyst(e)ine in vitamin B6 deficiency: A model for the study of cystathionine β–synthase deficiency. Journal of Nutrition 112, p. 1264–1272.CrossRefGoogle Scholar
Smolin, L. A., Crenshaw, T. D., Kurtycz, D. & Benevenga, N. J. (1983). Homocysteine accumulation in pigs fed diets deficient in vitamin B-6: relationship to atherosclerosis. Journal of Nutrition 113, p. 2022–2033.CrossRefGoogle ScholarPubMed
Stabler, S. P., Marcell, P. D., Podell, E. R., Allen, R. H., Savage, D. G. & Lindenbaum, J. (1988). Elevation of total homocysteine in serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. Journal of Clinical Investigation 81, p. 466–474.CrossRefGoogle ScholarPubMed
Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcomer, L. M., Upson, B., Ullmann, D., Tishler, P. V. & Hennekens, C. H. (1992). A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. Journal of the American Medical Association 268, p. 877–881.CrossRefGoogle ScholarPubMed
Starkebaum, G. & Harlan, J. M. (1986). Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation 77, p. 1370–1376.CrossRefGoogle ScholarPubMed
Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. & Witztum, J. L. (1989). Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 320, p. 915–924.Google ScholarPubMed
Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K., Mitchinson, M. J. & Brown, M. J. (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, p. 781–786.CrossRefGoogle ScholarPubMed
Taylor, L. M. Jr, DeFrang, R. D., Harris, E. J. Jr & Porter, J. M. (1991). The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. Journal of Vascular Surgery 13, p. 128–136.CrossRefGoogle ScholarPubMed
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 330, p. 1029–1035.CrossRefGoogle Scholar
Ubbink, J. B., Vermaak, W. J. H., van der Merwe, A. & Becker, P. J. (1993). Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. American Journal of Clinical Nutrition 57, p. 47–53.CrossRefGoogle ScholarPubMed
Ubbink, J. B., Vermaak, W. J. H., Van der Merwe, A., Becker, P. J., Delport, R. & Potgieter, H. C. (1994). Vitamin requirements for the treatment of hyperhomocysteinemia in humans. Journal of Nutrition 124, p. 1927–1933.CrossRefGoogle ScholarPubMed
Ueland, P. M., Refsum, H. & Brattstrom, L. (1992). Plasma homocysteine and cardiovascular disease. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function pp. 183–236 [Francis, R. B. Jr. New York: Marcel Dekker Inc.Google Scholar
Ueland, P. M., Refsum, H., Stabler, S. P., Malinow, M. R., Andersson, A. & Allen, R. H. (1993). Total homocyst(e)ine in plasma or serum: methods and clinical applications. Clinical Chemistry 39, p. 1764–1779.CrossRefGoogle ScholarPubMed
Uhlemann, E. R., Tenpas, J. H., Lucky, A. W., Schulman, J. D., Mudd, S. H. & Shulman, N. R. (1976). Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency. New England Journal of Medicine 295, p. 1283–1286.CrossRefGoogle ScholarPubMed
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Wilett, W. C. & Stampfer, M. J. (1994). A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25, p. 1924–1930.CrossRefGoogle ScholarPubMed
Walldius, G., Erikson, U., Olsson, A., Bergstrand, L., Hadell, K., Johansson, J., Kaijser, L., Lassvik, C., Molgaard, J., Nilsson, S., Schaferelinder, L., Stenport, G. & Holme, I. (1994). The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). Journal of Cardiology 74, p. 875–883.Google ScholarPubMed
Witztum, J. L. (1993). Role of oxidized low-density lipoprotein in atherogenesis. British Heart Journal 69, S12–S18.CrossRefGoogle Scholar
Witzum, J. L. & Steinberg, D. (1991). Role of oxidized LDL in atherogenesis. Circulation 83, p. 1785–1792.Google Scholar